CMI X-11S

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameCMI X-11S
Drug Alias NameDCA-I.V.CMI-X-11ACMI-CSX-1ACMI-X-11S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase inhibitors
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCardiometabolics
Active IndicationsN/A
Inactive IndicationsHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A